Sachi Bioworks
Sachi Bio is an RNA therapeutic platform company with a lead inflammasome inhibitor program that has shown rapid relief in aggressive Ulcerative Colitis and Multiple Sclerosis models (>90% reduction in inflammation in <1week), with excellent target product (oral, shelf-stable, long half-life) and safety-biodistribution profile.